A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

Article ID	Journal	Published Year	Pages	File Type
6062602	Journal of Allergy and Clinical Immunology	2016	19 Pages	PDF

Abstract

In this first randomized, double-blind, placebo-controlled trial of omalizumab in combination with food OIT, we found significant improvements in measurements of safety but not in outcomes of efficacy (desensitization and SU).

Keywords

CMA SCD APC SPT OFC Milk allergy cow's milk allergy antigen-presenting cell Omalizumab oral immunotherapy Skin prick test double-blind OIT sustained unresponsiveness placebo-controlled trial Oral food challenge Desensitization

Related Topics

Life Sciences Immunology and Microbiology Immunology

Preview

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

Authors

Robert A. MD, Jennifer S. MD, Robert MD, Kari MD, PhD, Alice K. MS, Peter PhD, Marshall MD, Hugh A. MD,